Vol 23, No 1 (2022)

Table of Contents

Editorial

The Importance of Real-World Evidence in Understanding Influenza Vaccine Effectiveness
Pietro Ferrara, Lorenzo Giovanni Mantovani
HTML PDF

Original research

Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy
Edoardo Mannucci, Gianni Ghetti
HTML PDF
[Budget Impact Analysis of the Adjuvanted Quadrivalent Influenza Vaccine in the Elderly in Italy]
Vincenzo Baldo, Marco Bellone
HTML PDF
[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy]
Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, Roberta Di Turi
HTML PDF
Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients with Advanced Follicular Lymphoma: A Cost Analysis
Marco Bellone, Lorenzo Pradelli, Rita Tavarozzi, Marco Ladetto, Giuliana Nepoti, Emanuele Guardalben, Daniela Ghislieri
HTML PDF
Artificial Urinary Sphincters as a Treatment for Post-Prostatectomy Severe Urinary Incontinence in Italy: A Cost-Utility Analysis
Francesco Mennini, Daniele Rossi, Andrea Marcellusi
HTML PDF
Cost-Effectiveness of Dimethyl Fumarate Compared to Teriflunomide for Relapsing Remitting Multiple Sclerosis Patients in Italy
Lorenzo Giovanni Mantovani, Paolo Angelo Cortesi, Alessandra Cardillo, Laura Santoni, Luca Prosperini
HTML PDF
Budget Saving Potential of Pegfilgrastim Biosimilar for the Treatment of Chemotherapy-Induced Febrile Neutropenia, in Italy
Patrizia Berto, Marco Bellone, Alice Sabinot, Carmine Pinto, Massimo Martino, Daniele Generali, Pier Luigi Carriero, Maria Domenica Sanna
HTML PDF